Quantitative MR imaging of brain iron: a postmortem validation study.

PURPOSE To investigate the relationship between transverse relaxation rates R2 and R2*, the most frequently used surrogate markers for iron in brain tissue, and chemically determined iron concentrations. MATERIALS AND METHODS This study was approved by the local ethics committee, and informed consent was obtained from each individual's next of kin. Quantitative magnetic resonance (MR) imaging was performed at 3.0 T in seven human postmortem brains in situ (age range at death, 38-81 years). Following brain extraction, iron concentrations were determined with inductively coupled plasma mass spectrometry in prespecified gray and white matter regions and correlated with R2 and R2* by using linear regression analysis. Hemispheric differences were tested with paired t tests. RESULTS The highest iron concentrations were found in the globus pallidus (mean ± standard deviation, 205 mg/kg wet mass ± 32), followed by the putamen (mean, 153 mg/kg wet mass ± 29), caudate nucleus (mean, 92 mg/kg wet mass ± 15), thalamus (mean, 49 mg/kg wet mass ± 11), and white matter regions. When all tissue samples were considered, transverse relaxation rates showed a strong linear correlation with iron concentration throughout the brain (r² = 0.67 for R2, r² = 0.90 for R2*; P < .001). In white matter structures, only R2* showed a linear correlation with iron concentration. Chemical analysis revealed significantly higher iron concentrations in the left hemisphere than in the right hemisphere, a finding that was not reflected in the relaxation rates. CONCLUSION Because of their strong linear correlation with iron concentration, both R2 and R2* can be used to measure iron deposition in the brain. Because R2* is more sensitive than R2 to variations in brain iron concentration and can detect differences in white matter, it is the preferred parameter for the assessment of iron concentration in vivo.

[1]  H. C. Torrey Bloch Equations with Diffusion Terms , 1956 .

[2]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[3]  T. Foster,et al.  A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. , 1984, Medical physics.

[4]  G A Johnson,et al.  MRI of brain iron. , 1986, AJR. American journal of roentgenology.

[5]  G A Johnson,et al.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. , 1986, Radiology.

[6]  J. Pujol,et al.  Biological significance of iron-related magnetic resonance imaging changes in the brain. , 1992, Archives of neurology.

[7]  J. Schenck,et al.  Health and Physiological Effects of Human Exposure to Whole‐Body Four‐Tesla Magnetic Fields during MRI , 1992, Annals of the New York Academy of Sciences.

[8]  C. Morris,et al.  Histochemical distribution of non-haem iron in the human brain. , 1992, Acta anatomica.

[9]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[10]  A. MacKay,et al.  In vivo visualization of myelin water in brain by magnetic resonance , 1994, Magnetic resonance in medicine.

[11]  E. Haacke,et al.  Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.

[12]  T. Bothwell Overview and mechanisms of iron regulation. , 2009, Nutrition reviews.

[13]  Thomas Becker,et al.  MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects , 1997, Psychiatry Research: Neuroimaging.

[14]  R M Henkelman,et al.  Diffusional anisotropy of T2 components in bovine optic nerve , 1998, Magnetic resonance in medicine.

[15]  J W Langston,et al.  The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. , 1999, Magnetic resonance imaging.

[16]  N. Andrews Disorders of iron metabolism. , 1999, The New England journal of medicine.

[17]  R A Knight,et al.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. , 1999, Radiology.

[18]  J. Jensen,et al.  Strong field behavior of the NMR signal from magnetically heterogeneous tissues , 2000, Magnetic Resonance in Medicine.

[19]  Ferritin and the response to oxidative stress. , 2001 .

[20]  R. Chandra,et al.  Quantitative model for the interecho time dependence of the CPMG relaxation rate in iron‐rich gray matter , 2001, Magnetic resonance in medicine.

[21]  R. Henkelman,et al.  Magnetization transfer in MRI: a review , 2001, NMR in biomedicine.

[22]  E. Haacke,et al.  High‐resolution BOLD venographic imaging: a window into brain function , 2001, NMR in biomedicine.

[23]  G. Bartzokis,et al.  Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases , 2004 .

[24]  J. Schenck,et al.  High‐field magnetic resonance imaging of brain iron: birth of a biomarker? , 2004, NMR in biomedicine.

[25]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[26]  Daniela Berg,et al.  Role of Iron in Neurodegenerative Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[27]  Glyn Johnson,et al.  Magnetic field correlation imaging , 2006, Magnetic resonance in medicine.

[28]  Reeti Tandon,et al.  High-field Magnetic Resonance Imaging of Brain Iron in Alzheimer Disease , 2006, Topics in magnetic resonance imaging : TMRI.

[29]  T. Montine,et al.  Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients , 2007, Magnetic resonance in medicine.

[30]  K. Uğurbil,et al.  Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts , 2007, Movement disorders : official journal of the Movement Disorder Society.

[31]  D. Pennell,et al.  Myocardial T  2* measurements in iron‐overloaded thalassemia: An in vivo study to investigate optimal methods of quantification , 2008, Magnetic resonance in medicine.

[32]  Xiaojun Xu,et al.  Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.

[33]  J. Duyn,et al.  Characterization of T2* heterogeneity in human brain white matter , 2009, Magnetic resonance in medicine.

[34]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[35]  David A Bennett,et al.  Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation , 2009, Magnetic resonance in medicine.

[36]  M. Muckenthaler,et al.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.

[37]  Jeremy J. Flint,et al.  Postmortem interval alters the water relaxation and diffusion properties of rat nervous tissue — Implications for MRI studies of human autopsy samples , 2009, NeuroImage.

[38]  J. Bulte,et al.  Direct saturation MRI: Theory and application to imaging brain iron , 2009, Magnetic resonance in medicine.

[39]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.